2008
DOI: 10.1016/j.joca.2008.02.008
|View full text |Cite
|
Sign up to set email alerts
|

The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation

Abstract: These in vitro and ex vivo experiments of human cartilage suggest that Helix-II and CTX-II could be released in part by different enzymatic pathways. Helix-II and CTX-II alone reflect only partially overall cartilage collagen degradation. These findings may explain why these two biological markers could provide complementary information on disease progression in OA.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
55
0
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 70 publications
(63 citation statements)
references
References 35 publications
6
55
0
1
Order By: Relevance
“…In line with this hypothesis, this enzyme has been identified as constituting the major proteolytic activity in osteoclasts, while immunohistochemical studies have specifically localized its presence in intracellular vesicles, in vesicles close to the ruffled border and within the resorption lacunae [6,[8][9][10]. However, growing evidence indicates that, in addition to Cathepsin K, other cysteine proteinases appear to participate in osteoclast-mediated proteolytic degradation of organic bone matrix [6,8,[10][11][12]. In particular, Cathepsin L, a lysosomal endopeptidase mainly involved in tissue degradation and extracellular matrix (ECM) remodeling, appears to make a significant contribution to this process [6,10,12,13].…”
Section: Introductionmentioning
confidence: 90%
See 4 more Smart Citations
“…In line with this hypothesis, this enzyme has been identified as constituting the major proteolytic activity in osteoclasts, while immunohistochemical studies have specifically localized its presence in intracellular vesicles, in vesicles close to the ruffled border and within the resorption lacunae [6,[8][9][10]. However, growing evidence indicates that, in addition to Cathepsin K, other cysteine proteinases appear to participate in osteoclast-mediated proteolytic degradation of organic bone matrix [6,8,[10][11][12]. In particular, Cathepsin L, a lysosomal endopeptidase mainly involved in tissue degradation and extracellular matrix (ECM) remodeling, appears to make a significant contribution to this process [6,10,12,13].…”
Section: Introductionmentioning
confidence: 90%
“…Several experimental and clinical investigations indicate that various proteolytic enzymes including matrix metalloproteinases and cysteine proteinases appear to play a major role in the physiological degradation of these macromolecules [6,8,32,49,73]. In particular, Cathepsin L can degrade cartilage-residing proteoglycans, such as aggrecan, and the non-helical telopeptide region of triple helical type I and II collagens [12,60,61,[77][78][79]. The triple helical domain, which is normally resistant to proteolysis, is not degraded by Cathepsin L and requires specific proteases such as Cathepsin K, which cleaves peptide bonds at multiple sites within this domain (Table 1) [9,12,83] It is now well established that the altered activity of these enzymes is responsible for the cartilage destruction and bone erosion associated with most of these diseases [73,[77][78][79][80][81][82].…”
Section: Cathepsin L In Pathological Bone Remodeling Processesmentioning
confidence: 99%
See 3 more Smart Citations